Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,304.00
(
-1.69%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
2.42%
)
Bitcoin
79,025.06
(
-2.51%
)
News Focus
News Focus
Post# of 257577
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 96900

Tuesday, 06/08/2010 9:29:49 AM

Tuesday, June 08, 2010 9:29:49 AM

Post# of 257577

Teva’s low-volume formulation will be a new branded drug, separate from regular Copaxone

What if the new low-volume formulation will be Teva's only version in the market (I assume Teva will switch patients and then withdraw the old product from the market).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today